Aldeyra Therapeutics Inc
Change company Symbol lookup
Select an option...
ALDX Aldeyra Therapeutics Inc
RBLX Roblox Corp
JMIA Jumia Technologies AG
MYDX MyDx Inc
WHF WhiteHorse Finance Inc
INDB Independent Bank Corp (Massachusetts)
SNOW Snowflake Inc.
FAUDX Strategic Advisers® Short Duration Fund
FFBC First Financial Bancorp
SMEBF Sime Darby Bhd
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Aldeyra Therapeutics, Inc., formerly Aldexa Therapeutics, Inc., is a biotechnology company. The Company's principal activities include raising capital and research and development activities. The Company's segment is the identification and development of a treatment for diseases related to high levels of aldehydes. The Company is focused on the development of products for diseases caused by inflammation and inborn errors of metabolism that are caused by naturally occurring toxic and pro-inflammatory chemical species known as aldehydes. The Company has developed a series of aldehyde traps, molecules that are designed to sequester and allow for the degradation of aldehydes. The Company's aldehyde trap, NS2, is a product candidate that is under development for the treatment of allergic conjunctivitis and related rare allergic ocular diseases, noninfectious anterior uveitis, sjogren-larsson syndrome (SLS) and succinic semi-aldehyde dehydrogenase deficiency.

Closing Price
$9.07
Day's Change
-0.11 (-1.20%)
Bid
--
Ask
--
B/A Size
--
Day's High
9.27
Day's Low
8.91
Volume
(Light)
Volume:
435,648

10-day average volume:
746,646
435,648

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PTON, PCT and ATER

7:26 pm ET June 9, 2021 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / June 9, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Peloton Interactive, Inc. (NASDAQ:PTON)

Class Period: September 11, 2020 - May 5, 2021

Lead Plaintiff Deadline: June 28, 2021

Peloton Interactive, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) in addition to the tragic death of a child, Peloton's Tread+ had caused a serious safety threat to children and pets as there were multiple incidents of injury to both; (2) safety was not a priority to Peloton as defendants were aware of serious injuries and death resulting from the Tread+, yet did not recall or suggest a halt of the use of the Tread+; (3) as a result of the safety concerns, the U.S. Consumer Product Safety Commission ("CPSC") declared that the Tread+ posed a serious risk to public health and safety and urgently recommended that consumers with small children cease using the Tread+; (4) the CPSC also found a safety threat to Tread+ users if they lost their balance; and (5) as a result of the foregoing, defendants' statements about Peloton's business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Learn about your recoverable losses in PTON: http://www.kleinstocklaw.com/pslra-1/peloton-interactive-inc-loss-submission-form?id=16753&from=1

PureCycle Technologies, Inc. (NASDAQ:PCT)

Class Period: November 16, 2020 - May 5, 2021

Lead Plaintiff Deadline: July 12, 2021

The complaint alleges that throughout the class period PureCycle Technologies, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the technology PureCycle licensed from Procter & Gamble is not proven and presents serious issues even at lab scale; (ii) the challenges posed by the availability and competition for the raw materials necessary to commercialize the licensed technology are significant; (iii) PureCycle's financial projections are baseless; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in PCT: http://www.kleinstocklaw.com/pslra-1/purecycle-technologies-inc-loss-submission-form?id=16753&from=1

Aterian, Inc. (NASDAQ:ATER)

Class Period: December 1, 2020 - May 3, 2021

Lead Plaintiff Deadline: July 12, 2021

Throughout the class period, Aterian, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's organic growth is plummeting; (ii) the Company's recent, self-lauded acquisitions were overpayments for flawed assets from questionable sources; (iii) Aterian's purported artificial intelligence software is a flawed product that lacks customer interest; (iv) Aterian uses rebate programs and paid or artificial reviews to pump up their product offerings; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in ATER: https://www.kleinstocklaw.com/pslra-1/aterian-inc-loss-submission-form?id=16753&from=1

Image: https://www.accesswire.com/users/newswire/images/651194/Klein-Logos_CTA-Logo-3.png

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.

Empire State Building

350 Fifth Avenue

59th Floor

New York, NY 10118

jk@kleinstocklaw.com

Telephone: (212) 616-4899

Fax: (347) 558-9665

www.kleinstocklaw.com

SOURCE: The Klein Law Firm

View source version on accesswire.com:

https://www.accesswire.com/651194/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-PTON-PCT-and-ATER

comtex tracking

COMTEX_388064221/2457/2021-06-09T19:26:19

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.